Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04004442 · ClinicalTrials.gov registry record · Phase 1

Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma

A Phase 1 study of Urothelial Carcinoma, sponsored by University of Oklahoma.

Active
Registry status
Phase 1
Development phase
19
Enrollment target
1
Study location

NCT04004442 is a Phase 1 study of Urothelial Carcinoma that is active but no longer recruiting, run by University of Oklahoma. The registered enrollment target is 19 participants, below the 239-participant average among 85 other Urothelial Carcinoma trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04004442, a Phase 1 study of Urothelial Carcinoma, is active but no longer recruiting, sponsored by University of Oklahoma.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to test the safety of avelumab and AVB-S6-500 and see what effects (good and bad) this combination treatment has on patients with advanced urothelial carcinoma.

Conditions Studied

Urothelial Carcinoma

Interventions

  • DRUG Avelumab
  • DRUG AVB-S6-500

Study Locations (1)

Oklahoma

  • Stephenson Cancer Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2020-02-17
Est. Completion 2026-10
Phase Phase 1

Sponsor

University of Oklahoma

358 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04004442

The ClinicalTrials.gov registry entry for NCT04004442 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 239-participant average among 85 other Urothelial Carcinoma trials with a reported enrollment target (92% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urothelial Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Avelumab is the first listed.

NCT04004442 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT04004442 about?

NCT04004442 is a clinical study titled "Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma". The purpose of this research study is to test the safety of avelumab and AVB-S6-500 and see what effects (good and bad) this combination treatment has on patients with advanced urothelial carcinoma.

What is the current status of trial NCT04004442?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2020-02-17. Estimated completion is 2026-10.

What conditions does trial NCT04004442 study?

This clinical trial studies the following conditions: Urothelial Carcinoma.

What interventions are being tested in trial NCT04004442?

The interventions under investigation include: Avelumab (DRUG), AVB-S6-500 (DRUG).

Who is sponsoring clinical trial NCT04004442?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04004442 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Urothelial Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Urothelial Carcinoma

All registered trials for this condition

Oklahoma

All trials with a study site in Oklahoma

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.